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ABSTRACT 
The mental and physical health of dementia caregivers has been shown to be worse than that of 
non-caregivers.  The present study was undertaken to investigate whether the caregivers of 
persons who take medications for behavior and mood problems in dementia are less depressed, 
and perceive their overall health to be better, than the caregivers of persons who do not take such 
medications.  Behavior and mood medications include anti-psychotics, anti-depressants, and 
anti-convulsants.  The Canadian Study of Health and Aging was used to identify informal, 
unpaid caregivers of persons with dementia (i.e., Alzheimer’s disease, vascular dementia, or 
other dementia [e.g., Parkinson’s disease]).  The caregivers of persons diagnosed with cognitive 
impairment not dementia or no cognitive impairment were also included in the study.  Care-
recipient use of behavior and mood medications was not found to affect caregiver depression 
(OR = 1.02; 95% CI = 0.62 to 1.66) or caregiver’s perceived overall health (OR = 1.35; 95% CI 
= 0.80 to 2.27). 
 
RÉSUMÉ 
Il est démontré que les donneurs de soins aux personnes atteintes de démence sont en moins 
bonne santé physique et mentale que les non-donneurs. Cette étude a été menée afin d’examiner 
si les donneurs de soins aux personnes qui prennent des médicaments pour traiter des problèmes 
comportementaux liés à la démence sont moins déprimés et se considèrent en meilleur état de 
santé général que les donneurs de soins aux personnes qui ne prennent pas de médicaments. Les 
médicaments traitants les troubles comportementaux comprennent les anti-psychotiques, les anti-
dépresseurs, et les anti-convulsifs. L’Étude sur la santé et le vieillissement au Canada a été 
employée afin d’identifier les donneurs de soins informels et bénévoles aux personnes atteintes 
de démence (i.e. la maladie d’Alzheimer, la démence vasculaire, ou d’autres formes de démence 
(comme la maladie de Parkinson)). Les donneurs de soins aux personnes atteintes de déficiences 
cognitives et non de démence ou aux personnes ne souffrant pas de déficiences cognitives ont 
aussi été inclus dans l’étude. Le recours aux médicaments pour traiter les problèmes de 
comportement ou de tempérament n’aurait pas d’incidence sur l’état dépressif des donneurs de 
soins (OR = 1.02; 95% IC = 0.62 à 1.66) ou la perception de leur état de santé générale (OR = 
1.35; 95% IC = 0.80 à 2.27).     
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INTRODUCTION 
Dementia caregivers can develop mental or physical health problems as a result of the 
multiplicity of tasks, and substantial time commitments involved in, caregiving.
1,2  Informal, 
unpaid caregivers have been found to be more likely than non-caregivers to report fair or poor 
(versus good or very good) health, to use psychotropic drugs, and to require medical care.
2  On 
account of these consequences, caregivers have been called the “hidden victims” of dementia.
3 
  There is evidence to indicate that caregivers may benefit when their loved ones take 
medications for dementia.  Medications such as donepezil, rivastigmine, galantamine, and 
memantine have been shown to reduce caregiver burden or the amount of time required to 
provide care.
4,5 
Persons with dementia are often prescribed more than just one type of medication during 
the course of treatment.  Besides the aforementioned four medications, which are used to 
symptomatically treat cognitive decline, persons with dementia may be prescribed drugs to help 
manage behavior and mood problems (e.g., delusions, anxiety, irritability).
6-11  These 
medications include anti-psychotics (e.g., risperidone, olanzapine, carnitine, physostigmine, 
linopirdine), anti-depressants (e.g., citalopram, sertraline, fluoxetine, fluvoxamine), and anti-
convulsants (e.g., divalproex sodium, carbamazepine). 
To date, there has been no examination of whether anti-psychotics, anti-depressants, or 
anti-convulsants can confer benefits to the caregivers of persons with dementia.  The caregiver 
impact of these medications is important to investigate because persons with dementia rely 
heavily on their caregivers, especially as the disease progresses.  Caregivers’ ability to fulfill this 
demanding role may be hampered by the stresses and strains of caregiving.  If these medications     
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can reduce problematic behaviors and moods, then persons with dementia may be easier to 
manage.  This could lead to reductions in caregiver health problems. 
The issue of caregiver benefits from behavior and mood drugs is especially vital because 
some anti-psychotics, anti-depressants, and anti-convulsants have been linked to adverse effects 
(e.g., stroke, further cognitive decline)
9,12-14 that could increase the difficulty of caregiving. 
This study was conducted to examine the associations between (1) the use of anti-
psychotics, anti-depressants, or anti-convulsants by persons with dementia and (2) caregiver 




Data for this study were drawn from the database of the Canadian Study of Health and Aging 
(CSHA), a population-based study of dementia in Canada.
15  The CSHA consisted of 9,008 
community-dwelling persons aged 65 years or over who were randomly sampled from 36 
nationwide communities and assessed for dementia.
16  Data were collected in 1991 (CSHA-1), 
1996 (CSHA-2), and 2001 (CSHA-3). 
The caregivers of a subgroup of the 9,008 persons in the CSHA were interviewed to 
obtain information on caregiver support networks, care-recipients’ ability to perform activities of 
daily living, care-recipients’ behavior disturbances, and caregiver burden and depression.  The 
subgroup was selected according to cognitive status. 
The sample for this study was drawn from the 1,135 informal, unpaid caregivers in 
CSHA-3.  These caregivers were friends or relatives of care-recipients and they were self-
identified as bearing primary responsibility for the provision of daily care.  Formal, paid     
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caregivers were not included in CSHA-3.  The sample was limited to CSHA-3 to control for 
differences in prescribing practices over time and to account for the fact that the composition of 
the caregiver cohort was not uniform over the three waves of the CSHA. 
Caregivers were entered into this study if they could be linked to a care-recipient in the 
CSHA-3 database (i.e., the caregiver/care-recipient dyad could be identified).  As well, the care-
recipient had to have undergone a clinical examination at CSHA-3 (n = 1,386).  Medication use 
was assessed only for persons who underwent the clinical examination.  A final inclusion 
criterion was the type of diagnosis.  Care-recipients in the dyad had to have an incidence 
diagnosis of probable or possible Alzheimer’s disease (AD), cognitive impairment not dementia 
(CIND), vascular dementia, or ‘other’ dementia (e.g., Parkinson’s disease).  Care-recipients 
without any cognitive impairment were also included because they could still be receiving anti-
psychotic, anti-depressant, or anti-convulsive medications for other health problems. 
 
Data Analysis 
Hypothesis.   The caregivers of care-recipients who take anti-psychotic, anti-depressant, 
or anti-convulsive medications are less likely to be depressed, and more likely to perceive 
themselves to be in better overall physical health, than the caregivers of care-recipients who do 
not take these medications. 
Main effect (independent) variable.   The main effect variable was ‘care-recipient’s use of 
a behavior and mood medication.’  The variable was dichotomized as follows: 1 = current use of 
at least one behavior and mood medication, namely risperidone, olanzapine, carnitine, 
physostigmine, linopirdine, citalopram, sertraline, fluoxetine, fluvoxamine, divalproex sodium,     
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or carbamazepine; 0 = no current use of at least one behavior and mood medication. 
Covariates.   To help test the hypothesis, the Caregiver Stress Process Model was used to 
select covariates from the CSHA dataset.
17  This model describes the interaction between the 
demands of care-recipients and the balancing of positive and negative caregiver experiences.  
The model contains three different groups of covariates: background/contextual covariates (e.g., 
sample characteristics), stressors (e.g., extent of required care), and mediators (e.g., coping 
resources available to caregivers).  Based on these groups, the following covariates were 
included in the analysis: 
1.  Background/contextual: caregiver sex and age, caregiver’s annual household income in 
Canadian dollars (< $30,000; $30,000 to $44,999; $45,000 to $69,999; ≥ $70,000), 
caregiver’s living arrangements (caregiver lives with care-recipient -- yes/no), care-
recipient’s living arrangements (community, medium institution, large institution), region 
of residence for caregiver/care-recipient dyad (Atlantic Canada, Quebec, Ontario, 
Prairies, British Columbia). 
2.  Stressor: Care-recipient’s ability to perform 14 ADLs (CSHA-3).  This covariate was 
based on the Activities of Daily Living scale from the Older Americans Resources and 
Services Project.
18,19  For each ADL, caregivers chose the response that best described 
the care-recipient’s ability to perform the activity in question.  Response options were: 
without any help, with some help, or completely unable to perform the ADL.  For this 
study, the covariate was dichotomized: 1 = any sort of help required for at least one ADL; 
0 = no help required for any ADL. 
3.  Mediator: Caregiver’s use of formal services in the past year (CSHA-3).  For this     
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covariate, caregivers were asked if they used each of nine formal services (e.g., 
homemaker, in-home nursing) in the past year to help provide care.  For this study, the 
covariate was dichotomized: 1 = use of at least one formal service; 0 = no use of any 
formal services. 
Additional covariates included the incidence diagnosis for care-recipients (no cognitive 
impairment, CIND, AD, vascular dementia, other specific dementia [e.g., Parkinson’s disease]) 
and the severity of dementia (mild, moderate, severe). 
Dependent variables.   The dependent variables were selected on the basis of the 
Caregiver Stress Process Model, which contained caregiver outcomes such as depression and 
health.  The dependent variables in this study were caregiver depression and caregiver’s 
perceived overall health.  A) Caregiver depression.  In CSHA-3, caregiver depression was 
measured using the short version of the Centre for Epidemiologic Studies Depression (CES-D) 
scale,
20,21 which has questions about the frequency of 10 depressive symptoms over the time 
span of one week.  Four response options were available for each symptom, and a score was 
assigned to each option: occurred for less than 1 day (score = 0), occurred for 1-2 days (score = 
1), occurred for 3-4 days (score = 2), occurred for 5-7 days (score = 3).  The total score could 
range from 0 to 30.  In the CSHA, caregivers with scores of 10 or more were considered to be 
depressed.  For this study, depression was dichotomized: 1 = depressed (CES-D score ≥ 10); 0 = 
not depressed (CES-D score < 10).  B) Caregiver’s perceived overall health.  In CSHA-3, 
caregiver’s perceived overall health was assessed using a question from the Short-Form Health 
Survey (SF-12): “In general, would you say your health is …”.  Five response options were 
available: excellent, very good, good, fair, or poor.  For this study, the variable was 
dichotomized: 1 = excellent/very good/good; 0 = fair/poor.     
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Regression.   Multiple logistic regression was used to examine the association between 
the main effect variable and each of the two dependent variables.  Regression analyses were 
conducted separately for each dependent variable. 
To avoid losing data on account of missing values, multiple imputation
22 was used to 
replace missing values with plausible values.  Five datasets were imputed using a conditional 
Gaussian model and all regression analyses were performed on each dataset.  Each analysis 
produced one set of parameter estimates per dataset.  To obtain a summary result for each 
analysis, the parameter estimates were combined using algorithms developed by Rubin
22 for the 
multiple imputation process. 
To ensure that the use of multiple imputation would not bias the study results, a 
comparative check was done for each of the study variables.  For categorical variables, the 
frequency distributions of the CSHA data (which had missing values) were compared to the 
combined frequency distributions of the five imputed datasets using Fisher’s exact test.  For 
continuous variables, medians were compared using the Wilcoxon rank-sum test. 
The regression analyses were conducted in accordance with the following steps: 
1.  Simple logistic regression was used to identify covariates that had a marginal effect (p < 
0.25)
23 on caregiver depression or caregiver’s perceived overall health. 
2.  To assess effect modification, an interaction term was formed for each covariate that had 
a marginal effect.  The interaction term included the covariate in question and the main 
effect variable.  Effect modification was deemed to be present if the p-value for the 
interaction term was < 0.05 in a model that also contained both the covariate in question 
and the main effect variable.     
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3.  Confounding was assessed for all covariates that were not effect modifiers, and for all 
covariates that did not have a marginal effect on the dependent variable in question.  A 
covariate was considered to be a confounder when the odds ratio of the main effect 
variable changed by ± 10% after the covariate had been added to a model containing only 
the main effect variable and the dependent variable. 
4.  A full regression model was built for each dependent variable.  The full model included 
the main effect variable and any covariates that (1) had marginal effects on the dependent 
variable in question or (2) that were found to be confounders.  The full model also 
included any interaction terms that were found to have p-values < 0.05 in point # 2 above. 
5.  The Hosmer and Lemeshow goodness-of-fit test was used to assess the accuracy of 
model fit. 
SAS v9.1 (The SAS Institute, Cary, NC) was used to obtain frequency distributions and 
conduct all regression analyses.  S-Plus v6.1 (Insightful Corp., Seattle, WA) was used to perform 
the multiple imputation.  The threshold for statistical significance was the 5% level (p < 0.05).  
 
RESULTS 
A total of 987 caregiver/care-recipient dyads met the inclusion criteria.  Broken down by 
diagnosis, these dyads included AD (n = 137 [14%]), vascular dementia (n = 43 [4%]), other 
dementias such as Parkinson’s disease (n = 12 [1%]), CIND (n = 462 [47%]), and no cognitive 
impairment (n = 333 [34%]).  The severity of disease in persons with dementia (n = 192) was 
almost evenly split between the mild and moderate categories, with 43% mild (n = 83), 49%     
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moderate (n = 94), and 8% severe (n = 15).  Of the caregivers, almost three-quarters were 
female, a third reported annual household incomes of $45,000 or more, nearly half were living in 
the same house as the care-recipient, and just over half reported using one or more formal 
community services in the past year.  Two-thirds of caregivers reported that care-recipients 
required help with one or more ADLs (Table 1). 
Only 6% (n = 57) of care-recipients were using a behaviour and mood drug (Table 1).  
Fifteen used an anti-psychotic, 32 used an anti-depressant, and 12 used an anti-convulsant.  Two 
of the care-recipients used medications from two classes, while the remaining 55 used a 
medication from one class only. 
  Close to 85% of caregivers were found to be free of depression.  The median CES-D 
score was 2 (25 to 75% interquartile range: 0 to 7).  Almost 85% of caregivers also perceived 
their overall health to be excellent, very good, or good, with most reporting very good or good 
(Table 1). 
  The comparisons of frequency distributions or medians showed that there were no 
differences between CSHA data with missing values and the imputed data (p > 0.05 for all 
comparisons).  This indicated that multiple imputation could be employed to prevent a loss of 
data in the regression analyses without introducing a bias due to the use of imputed values. 
The crude association between care-recipients’ use of behavior and mood medications 
and caregiver depression was positive.  The crude association between care-recipients’ use of 
behavior and mood medications and caregiver’s perceived overall health was also positive.  
However, the results were not statistically significant at the 5% level (Table 2). 
  The following covariates were found to have marginal effects on both dependent 
variables: caregiver lives in the same house as the care-recipient, caregiver sex, caregiver/care-    
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recipient region of residence, caregiver use of formal community services in the past year, care-
recipient needs help with ADLs, caregiver’s annual household income, and care-recipient sex.  
Severity of dementia was found to have marginal effects on caregiver depression.  None of these 
covariates were found to be effect modifiers. 
  The assessment of confounding identified care-recipient’s incidence diagnosis and 
caregiver age as confounders in the models for both dependent variables. 
  The covariates that had marginal effects on a dependent variable, or that were 
confounders, were included in the full model for that dependent variable. 
In the full model for depression, the presence of two related covariates (i.e., care-
recipient’s incidence diagnosis, severity of dementia) prevented the logistic model from 
adequately fitting the data.  The problem was resolved by combining the two covariates into a 
new variable with 11 categories (no cognitive impairment, CIND, and separate mild, moderate, 
and severe categories for each of the three types of dementia [AD, vascular dementia, other 
specific dementia]).  No cognitive impairment was the reference category. 
In the depression model (Table 3), there was no association between the care-recipient’s 
use of a behavior and mood medication and caregiver depression (odds ratio [OR] = 1.02; 95% 
confidence interval [CI] = 0.62 to 1.66).  The only part of any covariate that was statistically 
significant at the 5% level was Ontario as the region of residence for caregiver/care-recipient 
dyads (OR = 1.68; 95% CI = 1.12 to 2.53). 
  In the caregiver’s perceived overall health model (Table 4), there was a positive 
association between the care-recipient’s use of a behavior and mood medication and better 
caregiver health.  However, the association was not statistically significant at the 5% level (OR = 
1.35; 95% CI = 0.80 to 2.27).  Some covariates were statistically significantly associated with     
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caregiver health, including caregivers living in the same house as the care-recipient (OR = 0.65; 
95% CI = 0.52 to 0.81), Ontario (OR = 0.62; 95% CI = 0.45 to 0.87) or Quebec (OR = 1.51; 95% 
CI = 1.03 to 2.21) as the region of residence for caregiver/care-recipient dyads, and caregiver’s 
use of one or more formal community services in the past year (OR = 0.78; 95% CI = 0.62 to 
0.97). 
Hosmer and Lemeshow (HL) goodness-of-fit tests were done to check model fit.  Five 
HL tests—one per imputed dataset—were performed for the full model of caregiver depression 
and five others were performed for the full model of caregiver’s perceived overall health.  Test 
statistics (χ
2
8) ranged from 15.33 to 5.02 and p-values ranged from 0.05 to 0.76, thus indicating 
good model fit. 
 
DISCUSSION 
In this study, behavior and mood medications were not found to have an impact on dementia 
caregivers’ depression or perceived overall health. 
This is the first study of caregiver outcomes from the use of medications to treat behavior 
and mood in dementia.  Consequently, no direct comparisons can be made with other published 
research.  However, indirect comparisons can be made with research into another set of 
medications (i.e., cholinesterase inhibitors [ChEIs]) that are used to treat dementia.  There is only 
equivocal evidence for caregiver benefits from care-recipients’ use of ChEIs.  Lingler et al.
4 
reviewed caregiver burden and time in 17 dementia drug trials and conducted a meta-analysis of 
four trials on caregiver burden and six trials on time devoted to caregiving.  Effect sizes in the 
meta-analysis were measured using Cohen’s d,
24 where values between 0.20 and 0.50 indicate 
that active medications, relative to placebo, have small to medium beneficial effects on     
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outcomes.  Lingler et al. calculated tiny effect sizes, namely 0.18 (95% CI = 0.04 to 0.32) for 
burden and 0.15 (95% CI = 0.07 to 0.24) for time.  When the trials composing the meta-analysis 
were considered separately, the results in one of the four burden trials and four of the six time 
trials were not statistically significant at the 5% level. 
One of the trials in the Lingler et al.
4 meta-analysis—the AD2000 trial
25 of 5 mg and 10 
mg doses of the ChEI donepezil—contained a caregiver outcome that was similar to an outcome 
in this study (i.e., depression).  The AD2000 researchers measured the psychological well-being 
of caregivers using the 30-question General Health Questionnaire (GHQ-30),
26 which has a score 
range of 0-30.  Lower scores indicate better psychological well-being.  Over the course of 
follow-up, persons treated with donepezil had lower average scores than persons treated with 
placebo.  Average scores were 0.3 points lower (95% CI = –0.3 to 0.9) than placebo in the 5 mg 
donepezil group and 8.0 points lower (95% CI = –2.3 to 0.7) in the 10 mg donepezil group.  
However, as was the case in this study, the differences were not statistically significant at the 5% 
level. 
In this study, several covariates were found to be associated with caregiver depression 
and caregiver’s perceived overall health.  One interesting covariate was the region of residence 
for the caregiver/care-recipient dyad.  Caregivers in dyads residing in Ontario were more likely 
to be depressed and less likely to perceive better overall health than caregivers in dyads residing 
in Atlantic Canada (the reference category).  This is intriguing given that Ontario is Canada’s 
richest province and there are numerous health and social support services in place to assist 
caregivers and care-recipients.  Perhaps certain intangible community characteristics, which were 
not measured in the CSHA, can help account for this finding.  For example, Atlantic Canada is 
composed of many small, rural or semi-rural communities where grassroots-level familial or     
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communal support might provide some sort of a psychological boost to counteract the ill effects 
of caregiving.  Caregivers may feel less depressed because they are part of a tight-knit 
community that they believe will provide support in the event of hardship.  Similarly, the 
availability of such support could ease some of the difficulty of caring and lead to better-
perceived health.  In Ontario, the more urbanized nature of society could mean that community 
or family structures do not convey as strong a sense of support as in Atlantic Canada. 
In contrast to Ontario, caregivers in dyads residing in the Province of Quebec, which is 
also more urbanized than Atlantic Canada, were more likely to perceive their health as good or 
better than caregivers in Atlantic Canada.  Perhaps certain socio-cultural differences between 
predominantly French-speaking Quebec and English-speaking Atlantic Canada could account for 
this difference.  Further research into the social and cultural determinants of caregiver depression 
and perceived overall health is warranted given the importance of caregivers in the management 
of dementia patients. 
Two other covariates were associated with caregiver’s perceived overall health.  First, 
caregivers who used one or more formal community services in the past year were less likely to 
perceive their health to be good or better than caregivers who did not use any formal community 
services.  Second, caregivers who lived in the same house as the care-recipient were less likely to 
perceive their health to be good or better than caregivers who did not live in the same house. 
This study has some limitations.  First, all of the data were collected at the same point in 
time (i.e., at CSHA-3).  Cross sectional data lack temporality, which means a dependent variable 
can precede a main effect variable or a covariate (reverse causality bias
27).  Second, only a small 
number of care-recipients were using behavior and mood medications.  This could have 
underpowered the study with respect to detecting a main effect.  Third, missing values,     
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especially the large number of missing values for caregiver’s annual household income and 
caregiver age, necessitated the use of multiple imputation to prevent a loss of data for the 
regression analyses.  While there can be no perfect substitute for complete data, the use of 
multiple imputation allowed all of the subjects to be retained in the analyses.  If no imputation 
procedure was used, then caregivers with a missing value on only one variable would have been 
deleted from all regression analyses.  Indeed, multiple imputation is preferred over other forms 
of imputation (e.g., mean, hot deck, regression)
28 and a comparison of frequency distributions 
and medians showed that there were no differences between the CSHA data (with missing 
values) and the imputed data.  Fourth, data on some potentially important covariates were not 
available (e.g., intangible familial or community support).  This could have led to residual 
confounding.  Fifth, several potential caregiver outcomes (e.g., caregiver burden measured using 
the Zarit Burden Interview
29) were only assessed at CSHA-1 and CSHA-2, but not at CSHA-3.  
This limited the scope of outcomes that were available for study. 
In conclusion, no statistically significant associations were found between care-
recipients’ use of behavior and mood medications and caregiver depression or caregiver’s 
perceived overall health.  Given the importance of caregivers in dementia, and the negative 
impact that behavior and mood problems can have on the ability to provide care, future research 
should focus on an expanded set of caregiver outcomes.  This research should also be 
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Table 1. Sample Characteristics (n=987) 
    
 Frequency 
    
Characteristic No.  %
a 
    
    
Caregiver sex     
    
Male 256  26 
    
Female 731  74 
    
Caregiver’s annual household income     
    
< $30,000  255  26 
    
$30,000 - $44,999  209  21 
    
$45,000 - $69,999  160  16 
    
> $70,000  162  16 
    
Missing 201  20 
    
Caregiver lives in same house as care-recipient     
    
Yes 427  43 
    
No 560  57 
 
Caregiver use of formal community services in 
the past year 
  
    
No use  419  42 
    
Used ≥ 1  567  57 
    
Missing 1  <  1 
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Table 1. Continued 
    
 Frequency 
    
Characteristic No.  %
a 
    
    
Care-recipient needs help with ADLs     
    
No help required  307  31 
    
Help required with ≥ 1 ADLs  680  69 
    
Care-recipient uses a behavior and mood 
medication 
  
    
Yes 57  6 
    
No 930  94 
    
Caregiver’s perceived overall health     
    
Excellent 197  20 
    
Very good  328  33 
    
Good 301  31 
    
Fair 126  13 
    
Poor 27  3 
    
Missing 8  <  1 
    
Caregiver depressed     
    
Yes 149  15 
    
No 830  84 
    
Missing 8  1 
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Table 1. Continued 
    
 Frequency 
    
Characteristic No.  %
a 
    
    
Incidence diagnosis: Care-recipient    
    
No cognitive impairment  333  34 
    
Cognitive impairment not demented  462  47 
    
Alzheimer’s disease  137  14 
    
Vascular dementia  43  4 
    
Other specific dementia  12  1 
    
Severity of dementia: Care-recipient     
    
Mild 83  8 
    
Moderate 94  10 
    
Severe 15  81 
    
Care-recipients’ living arrangements     
    
Community 978  99 
    
Medium institution  5  0.5 
    
Large institution  3  0.3 
    
Missing 1  0.1 
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Table 1. Continued 
    
 Frequency 
    
Characteristic No.  %
a 
    
    
Region of Residence: Caregiver/care-recipient 
dyad 
  
    
Atlantic 183  19 
    
Quebec 226  23 
    
Ontario 212  21 
    
Prairies 182  18 
    
British Columbia  184  19 
    
Care-recipient sex     
    
Male 408  41 
    
Female 579  59 
    
Caregiver age (years)  66 (56—83)
b; missing = 937 (95)
c 
    
Care-recipient age (years)  84 (80—89)
b; missing = 0 (0)
c 
    
 
a. Percentages may not add to 100% because of rounding error. 
 
b. Median (25—75% interquartile range). 
 
c. Number (%) of missing values. 
 
ADL = activity of daily living.     
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Table 2. Crude Associations Between Care-Recipient’s Use of A Behavior and Mood 
Medication and Caregiver Depression and Caregiver’s Perceived Overall Health (n = 987) 
    
 Dependent  Variable 
  
    
 Caregiver  Depression
a Caregiver’s  Perceived 
Overall Health
b 
    
Main Effect Variable  OR (95% CI)  OR (95% CI) 
    
    
Care-recipient’s use of a behavior and 
mood medication 
  
    
Yes 1.25  1.16 
 (0.89—1.74)  (0.77—1.74) 
    
No 1.00  1.00 
    
 
a. Yes/no (no = reference category). 
  
b. Excellent—vary good—good/fair—poor (fair—poor = reference category). 
 
OR = odds ratio; CI = confidence interval.     
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Table 3. Final Model for Care-Recipient’s Use of A Behavior and Mood Medication and 
Caregiver Depression (n = 987) 
  
Variable  OR (95% CI) 
  
  
Care-recipient uses a behavior and mood medication   
  




Caregiver lives in same house as care-recipient   
  




Region of residence: Caregiver/care-recipient dyad   
  
British Columbia  0.97 (0.59—1.59) 
  
Prairies 1.20  (0.75—1.93) 
  
Ontario 1.68  (1.12—2.53) 
  




Caregiver sex   
  




Patient sex   
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Table 3. Continued 
  
Variable  OR (95% CI) 
  
  




Used ≥ 1  1.23 (0.92—1.63) 
  
No use  1.00 
    
Care-recipient needs help with ADLs   
  
Help required with ≥ 1 ADLs  1.40 (1.01—1.95) 
  
No help required  1.00 
  
Annual household income   
  
> $70,000  0.64 (0.28—1.45) 
  
$45,000 - $69,999  0.98 (0.57—1.69) 
  
$30,000 - $44,999  1.22 (0.81—1.84) 
  
< $30,000  1.00 
  
Incidence diagnosis and severity: Care-recipient   
  
Other specific dementia – severe  4.20 (0.19—91.07) 
  
Other specific dementia – moderate  0.58 (0.07—4.98) 
  
Other specific dementia – mild  2.03 (0.16—25.99) 
  
Vascular dementia – severe  2.65 (0.32—22.17) 
  
Vascular dementia – moderate  0.53 (0.13—2.09) 
  
Vascular dementia – mild  1.21 (0.34—4.30) 
  
Alzheimer’s disease – severe  1.06 (0.15—7.25) 
  
Alzheimer’s disease – moderate  0.92 (0.41—2.07) 
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Table 3. Continued 
  
Variable  OR (95% CI) 
  
 




Alzheimer’s disease – mild  0.51 (0.21—1.28) 
  
Cognitive impairment not demented  0.57 (0.18—1.79) 
  
No cognitive impairment  1.00 
  
Caregiver age  1.05 (0.94—1.18) 
  
  
 OR = odds ratio; CI = confidence interval; ADLs = activities of daily living.    
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Table 4. Final Model for Care-Recipient’s Use of A Behavior and Mood Medication and 
Caregiver’s Perceived Overall Health (n = 987) 
 
Variable  OR (95% CI) 
  
  
Care-recipient uses a behavior and mood medication   
  




Caregiver lives in same house as care-recipient   
  




Region of residence: Caregiver/care-recipient dyad   
  
British Columbia  0.95 (0.65—1.40) 
  
Prairies 0.90  (0.61—1.33) 
  
Ontario 0.62  (0.45—0.87) 
  




Caregiver sex   
  




Patient sex   
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Table 4. Continued 
 
Variable  OR (95% CI) 
  
  




Used ≥ 1  0.78 (0.62—0.97) 
  
No use  1.00 
    
Care-recipient needs help with ADLs   
  
Help required with ≥ 1 ADLs  0.84 (0.65—1.08) 
  
No help required  1.00 
  
Annual household income   
  
> $70,000  1.41 (0.80—2.50) 
  
$45,000 - $69,999  1.11 (0.69—1.76) 
  
$30,000 - $44,999  1.01 (0.69—1.48) 
  
< $30,000  1.00 
  
Incidence diagnosis: Care-recipient   
  
Other specific dementia  1.16 (0.31—4.41) 
  
Vascular dementia   1.05 (0.47—2.31) 
  
Alzheimer’s disease  1.14 (0.62—2.08) 
  
Cognitive impairment not demented  0.84 (0.49—1.43) 
  
No cognitive impairment  1.00 
  
Caregiver age  0.99 (0.92—1.07) 
  
 
OR = odds ratio; CI = confidence interval; ADLs = activities of daily living. SEDAP RESEARCH PAPERS: Recent Releases
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